These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1251 related articles for article (PubMed ID: 28625333)

  • 41. [Liver resection in a case of multiple liver metastases of gastric cancer following hepatic arterial infusion chemotherapy].
    Kobayashi T; Katayama K; Nagano H; Taguchi S; Niimoto S; Hirose K; Yamaguchi A; Nakagawara G
    Gan To Kagaku Ryoho; 1996 Sep; 23(10):1321-4. PubMed ID: 8831746
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of stage IV gastric cancer with induction chemotherapy using S-1 and cisplatin followed by curative resection in selected patients.
    Saito M; Kiyozaki H; Takata O; Suzuki K; Rikiyama T
    World J Surg Oncol; 2014 Dec; 12():406. PubMed ID: 25551581
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complete Response Obtained with S-1 Plus CDDP Therapy in a Patient with Multiple Liver Metastases from Gastric Cancer.
    Nonoshita T; Otsuka S; Inagaki M; Iwagaki H
    Hiroshima J Med Sci; 2015 Dec; 64(4):65-9. PubMed ID: 26964156
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Arterioportal shunt incidental to treatment with oxaliplatin that mimics recurrent gastric cancer.
    Kim HB; Park SG
    World J Gastroenterol; 2017 Sep; 23(33):6187-6193. PubMed ID: 28970735
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer.
    Saiura A; Umekita N; Inoue S; Maeshiro T; Miyamoto S; Matsui Y; Asakage M; Kitamura M
    Hepatogastroenterology; 2002; 49(46):1062-5. PubMed ID: 12143202
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resection of small bowel adenocarcinoma liver metastasis combined with neoadjuvant and adjuvant chemotherapy results in extended disease-free period--a case report.
    Eigenbrod T; Kullmann F; Klebl F
    Int J Gastrointest Cancer; 2006; 37(2-3):94-7. PubMed ID: 17827529
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metastatic gastric cancer: Does the site of metastasis make a difference?
    Tan HL; Chia CS; Tan GHC; Choo SP; Tai DW; Chua CWL; Ng MCH; Soo KC; Teo MCC
    Asia Pac J Clin Oncol; 2019 Feb; 15(1):10-17. PubMed ID: 29920947
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Postoperative chemotherapy followed by conformal concomitant chemoradiotherapy in high-risk gastric cancer.
    Quero L; Bouchbika Z; Kouto H; Baruch-Hennequin V; Gornet JM; Munoz N; Cojean-Zelek I; Houdart R; Panis Y; Valleur P; Aparicio T; Maylin C; Hennequin C
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):574-80. PubMed ID: 22099038
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical features and prognosis analysis of 21 gastric cancer patients with pathological complete response after neoadjuvant chemotherapy].
    Peng L; Yang W; Zhang Z; Liu H; Hua Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Oct; 20(10):1168-1173. PubMed ID: 29130233
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer.
    Dikken JL; Jansen EP; Cats A; Bakker B; Hartgrink HH; Kranenbarg EM; Boot H; Putter H; Peeters KC; van de Velde CJ; Verheij M
    J Clin Oncol; 2010 May; 28(14):2430-6. PubMed ID: 20368551
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A case with synchronous multiple liver metastases from gastric carcinoma: postoperative long-term disease-free survival.
    Munekage M; Okabayashi T; Hokimoto N; Sugimoto T; Maeda H; Namikawa T; Dabanaka K; Kobayashi M; Araki K; Hanazaki K
    Langenbecks Arch Surg; 2009 Jul; 394(4):749-53. PubMed ID: 19002484
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Conversion surgery for stage IV gastric cancer with multiple liver metastases with a complete pathological response to S-1 plus oxaliplatin therapy.
    Sakoh T; Eto K; Iwagami S; Yoshida N; Kosumi K; Iwatsuki M; Baba Y; Miyamoto Y; Yoshii D; Baba H
    Clin J Gastroenterol; 2024 Jun; 17(3):419-424. PubMed ID: 38466470
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.
    Goéré D; Benhaim L; Bonnet S; Malka D; Faron M; Elias D; Lefèvre JH; Deschamps F; Dromain C; Boige V; Dumont F; De Baere T; Ducreux M
    Ann Surg; 2013 Jan; 257(1):114-20. PubMed ID: 23235397
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcomes of surgical resection for gastric cancer liver metastases: a retrospective analysis.
    Kawahara K; Makino H; Kametaka H; Hoshino I; Fukada T; Seike K; Kawasaki Y; Otsuka M
    World J Surg Oncol; 2020 Feb; 18(1):41. PubMed ID: 32093729
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI.
    Al-Batran SE; Goetze TO; Mueller DW; Vogel A; Winkler M; Lorenzen S; Novotny A; Pauligk C; Homann N; Jungbluth T; Reissfelder C; Caca K; Retter S; Horndasch E; Gumpp J; Bolling C; Fuchs KH; Blau W; Padberg W; Pohl M; Wunsch A; Michl P; Mannes F; Schwarzbach M; Schmalenberg H; Hohaus M; Scholz C; Benckert C; Knorrenschild JR; Kanngießer V; Zander T; Alakus H; Hofheinz RD; Roedel C; Shah MA; Sasako M; Lorenz D; Izbicki J; Bechstein WO; Lang H; Moenig SP
    BMC Cancer; 2017 Dec; 17(1):893. PubMed ID: 29282088
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A case of gastric endocrine cell carcinoma with liver metastases treated with S-1/CDDP].
    Ohhinata R; Iwasaki Y; Ohashi M; Iwanaga T; Takahashi K; Yamaguchi T; Matsumoto H; Nakano D; Maeda Y; Sasaki E
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2508-10. PubMed ID: 21224622
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinicopathological characteristics, diagnosis, treatment, and outcomes of primary gastric adenosquamous carcinoma.
    Chen H; Shen C; Yin R; Yin Y; Chen J; Han L; Zhang B; Chen Z; Chen J
    World J Surg Oncol; 2015 Apr; 13():136. PubMed ID: 25889482
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The successfully curative treatment of advanced gastric adenocarcinoma with multiple liver metastases and paraaortic lymph node metastases by salvage operation following the biweekly paclitaxel and S-1 combination chemotherapy: a case report.
    Sasaki K; Natsugoe S; Aridome K; Ishigami S; Hokita S; Aikou T
    Hepatogastroenterology; 2007 Dec; 54(80):2421-4. PubMed ID: 18265679
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term outcomes after surgical resection for gastric cancer liver metastasis: an analysis of 64 macroscopically complete resections.
    Takemura N; Saiura A; Koga R; Arita J; Yoshioka R; Ono Y; Hiki N; Sano T; Yamamoto J; Kokudo N; Yamaguchi T
    Langenbecks Arch Surg; 2012 Aug; 397(6):951-7. PubMed ID: 22615045
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy for D2-resected gastric cancer.
    Shim HJ; Kim KR; Hwang JE; Bae WK; Ryu SY; Park YK; Nam TK; Chung IJ; Cho SH
    Cancer Chemother Pharmacol; 2016 Mar; 77(3):605-12. PubMed ID: 26846507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 63.